Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Tanner

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2024
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective InvestigationE Ray Dorsey, Dan Kinel, Meghan E Pawlik, et al.
Annals of Neurology|May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trialEllen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Annals of Neurology|June 17, 2020
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseDavid J Irwin, Janel Fedler, Christopher S Coffey, et al.
Annals of Neurology|January 26, 2012
Head injury, α-synuclein Rep1, and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 28, 2019
Cervical dystonia incidence and diagnostic delay in a multiethnic populationSara C LaHue, Kathleen Albers, Samuel Goldman, et al.
Parkinsonism & Related Disorders|February 11, 2019
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2014
Peptidoglycan recognition protein genes and risk of Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2024
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective InvestigationE Ray Dorsey, Dan Kinel, Meghan E Pawlik, et al.
Annals of Neurology|May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trialEllen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Annals of Neurology|June 17, 2020
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseDavid J Irwin, Janel Fedler, Christopher S Coffey, et al.
Annals of Neurology|January 26, 2012
Head injury, α-synuclein Rep1, and Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 28, 2019
Cervical dystonia incidence and diagnostic delay in a multiethnic populationSara C LaHue, Kathleen Albers, Samuel Goldman, et al.
Parkinsonism & Related Disorders|February 11, 2019
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2014
Peptidoglycan recognition protein genes and risk of Parkinson's diseaseSamuel M Goldman, Freya Kamel, G Webster Ross, et al.
Pageof 21